New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
16:39 EDTCRM, VVUS, AET, SQNM, ZLC, TLYS, STJOn The Fly: Closing Wrap
Stocks on Wall Street were higher on the day, the last full trading session of the week ahead of Thursday's holiday and Friday's half day. Jobless data that was in-line with expectations did little to move the markets before the open, but the markets slowly moved higher through the session, although volume remained light. Just after midday, news crossed that a cease fire between Israel and Hamas had been reached, tempering fears that the conflict could escalate to involve other players in the region and have broader economic impacts... ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 410,000, which was in-line with forecasts. Markit's "flash" November flash PMI rose to 52.4 from 51.0 in October. The final November reading of the University of Michigan Sentiment index slipped to 82.7 from its 84.9 preliminary reading. The leading indicators edged up 0.2% in October to 96.0 from 95.8 in September. In Europe, the region's finance ministers and the IMF were unable to reach a bailout agreement for Greece and will meet again on Monday with an eye on resolving the remaining disagreements. In Asia, Japanese exports fell 6.5% in October, lower than expectations for a 4.9% decline... COMPANY NEWS: Salesforce.com's (CRM) Q3 results beat on the top and bottom lines and RW Baird and Wells Fargo reiterated their Outperform ratings on the stock following the report, and shares of Salesforce.com traded higher on the session, settling up $12.88, or 8.83%, to $158.78... MAJOR MOVERS: Among notable gainers were shares of VIVUS (VVUS), up $1.38, or 13.33%, to $11.73 after Aetna (AET) posted a policy revision that expands coverage of the company's weight-loss drug Qsymia. Also higher were shares of Sequenom (SQNM), up 56c, or 15.18%, to $4.25 after a committee of the American College of Obstetricians and Gynecologists recommended that cell-free fetal DNA testing be offered to certain at-risk patients. Among the noteworthy were shares of Zale (ZLC), down over $2.23, or 29.97%, to $5.21, and Tilly's (TLYS), down $2.69, or 17.18%, to $12.97 after reporting earnings. Also lower were shares of St. Jude Medical (STJ), which fell $4.34, or 12.15%,to $31.37 after an FDA inspection report cited serious flaws in its oversight of design changes in its Durata line of defibrillator leads... INDICES The Dow was up 48.38, or 0.38%, to 12,836.89; the S&P 500 was up 3.22, or 0.23%, to 1,391.03;the Nasdaq was up 9.87, or 0.34%, to 2,926.55.
News For CRM;VVUS;AET;SQNM;ZLC;TLYS;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
07:34 EDTSTJEnteroMedics names Brad Hancock Chief Commercial Officer
Subscribe for More Information
October 28, 2014
07:23 EDTCRMSalesforce.com added to Best Ideas List at Morgan Stanley
Subscribe for More Information
06:05 EDTAETAetna reports Q3 Health Care business revenue $14B
The 14% increase is due primarily to membership growth in both of Aetna's Government and Commercial businesses, as well as the effects of pricing actions designed to recover the fees and taxes mandated by health care reform. Reports Q3 Group Insurance revenue $621.4M; Reports Q3 Large Case Pensions revenue $86.3M
06:04 EDTAETAetna reports Q3 medical membership totaled 23.6M at September 30, 2014
Sequentially, third-quarter 2014 medical membership increased by 470,000 due to growth in Aetna's Commercial ASC and Government products. Aetna's third-quarter 2014 Commercial MBR increased over the prior year's MBR primarily as a result of medical cost performance in the smaller middle-market business, costs associated with new hepatitis C treatments, and performance in the individual business, which reflects the impact of programs mandated by health care reform in 2014. This result was partially offset by higher premiums driven in part by pricing actions designed to recover the fees and taxes mandated by health care reform. In the third quarter of 2014, we experienced favorable development of prior-period health care cost estimates in each of our core products, primarily attributable to second quarter 2014 performance.
06:03 EDTAETAetna projects Coventry integratoin earnings accretion of 60c per share
Subscribe for More Information
06:03 EDTAETAetna raises FY14 operating EPS to $6.60-$6.70 from $6.45-$6.60, consensus $6.59
06:02 EDTAETAetna reports Q3 operating EPS $1.79, consensus $1.58
Subscribe for More Information
October 27, 2014
15:36 EDTAETNotable companies reporting before tomorrow's open
Subscribe for More Information
08:04 EDTSTJSt. Jude Medical receives FDA approval of Tacticath Quartz catheter
Subscribe for More Information
October 26, 2014
15:53 EDTCRMSalesforce looks to establish presence in healthcare, Reuters says
Subscribe for More Information
October 23, 2014
13:40 EDTAETWal-Mart's Sam's Club offering services to small businesses
Subscribe for More Information
October 22, 2014
07:21 EDTSTJU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
October 21, 2014
07:45 EDTCRMMicrosoft CEO touts cloud revenue run-rate over $4B, BI reports
At a press event yesterday, Microsoft (MSFT) CEO Satya Nadella provided a number of figures about the strong performance of the company's Azure cloud business, including a revenue run rate of nearly $4.4B and that Azure is adding 10,000 new customers every week to its 350M active directory user base, reported Business Insider, which noted that Amazon Web Services (AMZN) is estimated to have roughly $4B in annual sales and that Salesforce.com (CRM) had a little over $4B in revenues last year. Reference Link
06:40 EDTCRMForrester: Adobe becomes marketing cloud leader, VentureBeat reports
Subscribe for More Information
October 20, 2014
07:12 EDTSTJCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
October 17, 2014
07:44 EDTCRMSalesforce.com moving in right direction in every way, says Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use